UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) and seven regional collaborators will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.

Do probiotics supplements really make a difference during antibiotic treatment? Probably not, says research

Researchers evaluated previous work conducting controlled trials of patients undergoing antibiotic therapy.

July 24, 2023

Sirolimus by OrphAI Therapeutics for Pulmonary Arterial Hypertension: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 6, 2023

Go After the Big E-Cigarette Makers, Not Vape Shops, House Members Tell FDA

Members of a House committee examining FDA’s regulation of the food and tobacco industries had a question for the agency’s representatives at a hearing Tuesday:

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.